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ABSTRACT 
Background: The etiology of endometrial lesions varies from benign to malignant. Early 
detection and management of malignancy give the best prognosis for the patient. While studies 
in America and Europe report a 3-5% risk of malignancy in women below 50 years and a 
significant increase up to 75-80% in postmenopausal, the availability of national 
epidemiologic data is limited, therefore the study is held.Method: A descriptive- retrospective 
study. Total sampling obtained from endometrial specimens in Pathology Diagnostic Center-
Prof JH Lunardhi, Sp.PA(K) from  2015 to 2017, while gestation-related, inadequate sample, 
and incomplete report are excluded. Data analyzed by IBM SPSS 23.0 version. Result: Data 
of 560 samples, 90% from curettage, 8% hysterectomy, and 2% hysteroscopy. The majority 
belonged to the 40-49 age group (44.3%). Secretory phase endometrium is the most common 
finding in the age group of 20-29 years (26.9%). Proliferative phase endometrium is the most 
common finding. The highest incidence of endometrial hyperplasia occurred in the age group 
of 40-49 years, for both typical and non-atypical. Endometrial malignancy was found mostly 
in the 50-59 years (37.03%). Conclusion: The prevalence of endometrial lesions differed 
according to age groups, with physiological changes, endometritis, polyps, and hyperplasia 
were most common under 50 years old and the risk of malignancy increased 4.39 times (p.00) 
beyond 50 years old.  
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ABSTRAK 
Latar Belakang: Etiologi lesi endometrium bervariasi dari kelainan jinak sampai keganasan. 
Deteksi dan tata laksana dini pada keganasan memberikan prognosis terbaik. Penelitian di 
Amerika dan Eropa melaporkan 3-5% resiko keganasan pada usia dibawah 50 tahun dan 
meningkat signifikan sampai 75-80% paska menopause. Data epidemiologi nasional masih 
terbatas sehingga penelitian ini  perlu dilaksanakan. Metode: Studi deskriptif retrospektif. 
Total sampel dari spesimen endometrium di Sentra Diagnostik Patologi Prof. JH Lunardhi, 
SpPA(K) tahun 2015-2017  dengan  kriteria eksklusi lesi terkait gestasi, sampel tidak adekuat 
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dan laporan tidak lengkap. Data dianalisa dengan IBM SPSS  versi 23.0. Hasil: Data 560 
sampel endometrium, 90% kuretase diikuti dengan histerektomi 8% dan histeroskopi 2%, yang 
didominasi kelompok usia 40-49 tahun (44,3%).  Endometrium fase sekresi merupakan temuan 
yang terbanyak pada kelompok usia 20-29 tahun (26,9%). Endometrium fase proliferasi 
merupakan temuan terbanyak pada kelompok usia 30-69 tahun dan usia 80-89 tahun. Pada 
kelompok usia 70-79 tahun, temuan yang terbanyak adalah hiperplasia endometrium non-
atipikal (50%). Kejadian hiperplasia endometrium paling banyak terjadi pada kelompok usia 
40-49 tahun, baik pada non-atipikal (55,3%) maupun atipikal (83,3%). Keganasan pada 
endometrium paling banyak ditemukan pada kelompok usia 50-59 tahun (37,03%). 
Kesimpulan: Prevalensi lesi endometrium berbeda sesuai kelompok umur, pada usia dibawah 
50 tahun didapatkan endometritis, polip dan hiperplasia. Pada usia diatas 50 tahun risiko 
keganasan meningkat 4,39 kali lipat ( p=0,00) 
Kata Kunci: Lesi Endometrium, Hiperplasia, Umur, Menopaus, Keganasan 
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BACKGROUND 
Endometrial lesions may occur 
anytime in a woman’s life, which prompts 
them to visit medical facilities with the 
chief complaint of vaginal bleeding. The 
etiology varies from benign changes caused 
by hormone exposure, endometrial polyps, 
chronic endometritis, endometrial 
hyperplasia, and endometrial malignancy. 
Endometrial hyperplasia is potentially 
progressed to endometrial malignancy 
according to clinicopathology and 
epidemiology past studies [1]. In 2018, the 
estimated prevalence of endometrial 
cancers was 33.9/100.000 and becoming 
the second-largest cancer prevalence 
worldwide after cervical cancer[2]. 
Histopathology abnormalities vary 
among age groups of women. Endometrial 
lesion among young women is caused by 
hormone imbalance, while endometrial 
hyperplasia and endometrial malignancy 
occur among older women [3].  
Data on the prevalence of 
endometrial lesions based on age helps the 
physician in managing patient complaints 
and stakeholders in establishing policies for 
screening in high-risk age groups. The 
epidemiological study regarding the 
prevalence of endometrial lesions in 
Indonesia is limited, therefore a thorough 
report is needed. 
 




 This research was a descriptive, 
observational, and retrospective study. The 
population was women who had undergone 
pathology examinations of the 
endometrium from  January  2015 to  
December 2017. The total sampling method 
includes endometrial examinations 
obtained from curettage, hysteroscopy, and 
hysterectomy. The exclusion criteria were 
gestation-related lesions,  inadequate 
samples, and incomplete reports. The 
research was carried out from October 1, 
2020, to December 31, 2020, at the 
Anatomical Pathology Clinic run by Prof. 
JH Lunardhi in Surabaya and analyzed 
using the IBM SPSS version 23.0 program. 
The chart of epidemiology distribution is 
shown in numbers and percentages. 
RESULT 
560 reports of the endometrial examination 
met the inclusion criteria, with 90% of 
specimens obtained by curettage, 2% 
hysteroscopy, and 8% hysterectomy. 
Hysteroscopic classifications are presented 




Figure 1. Distribution of Procedures 
Done to Obtained Endometrial Tissue. 
Figure 2. Distribution of procedures done 
based on age group 
 
 
Figure 3. Distribution of  age underwent sampling procedures 
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 Table 1. Result of Biopsy Based on Age 
 Age Group 
Total 
20-29 30-39 40-49 50-59 60-69 70-79 80-89 
Irregular Shedding  1 (3,8%) 10 (6,0%) 16 (6,4%) 4 (4,4%) 0 (0%) 0 (0%) 0 (0%) 31 (5,5%) 
Endometrial polyp 6 (23,1%) 34 (20,2%) 27 (10,8%) 10 (11,1%) 1 (5,0%) 0 (0%) 0(0%) 78(13,9%) 
Long Standing Progesterone Effect 2 (7,7%) 7 (4,2%) 4(1,6%) 0(0%) 0(0%) 0(0%) 0 (0%) 13(2,3%) 
Undifferentiated Carcinoma 0 (0%) 1 (0,6%) 0 (0%) 1 (1,1%) 0 (0%) 0(0%) 0 (0%) 2 (0,4%) 
Atrophic Endometrium 0 (0%) 0 (0%) 0 (0%) 2 (2,2%) 1 (5%) 0 (0%) 0 (0%) 3 (0,5%) 
Atrophic Endometrium with Cystic Changes 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (5%) 0 (0%) 0 (0%) 1 (0,2%) 
Proliferative  Phase Endometrium  6(23,1%) 45(26,8%) 65(26,1%) 37(41,1%) 9 (45%) 2 (33,3%) 2(66,7%) 166 (29,5%) 
Secretory Phase Endometrium 7 (26,9%) 31 (18,5%) 41(16,5%) 4 (4,4%) 0(0%) 0(0%) 0(0%) 83 (14,7%) 
Nonatypical Hyperplasia 1 (3,8%) 27 (16,1%) 68 (27,3%) 21 (23,3%) 3 (15%) 3 (50%) 0(0%) 123 (21,8%) 
Atypical Hyperplasia 1 (3,8%) 0 (0%) 10 (4%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 12 (2,1%) 
Chronic Endometritis 1 (3,8%) 7 (4,2%) 11  (4,4%) 1 (1,1%) 1 (5%) 1 (16,7%) 1 (33,3%) 23 (4,1%) 
Grade 1 Endometrioid Carcinoma 0 (0%) 2 (1,2%) 0 (0%) 2 (2,2%) 0 (0%) 0 (0%) 0 (0%) 4 (0,7%) 
Grade 2 Endometrioid Carcinoma 1 (3,8%) 0 (0%) 4 (1,6%) 2 (2,2%) 3 (15%) 0 (0%) 0 (0%) 10 (1,8%) 
Grade 3 Endometrioid Carcinoma  0 (0% 1 (0,6%) 0 (0,0%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 2 (0,4%) 
High grade endometrial Adenocarcinoma  0 (0%) 0 (0%) 0 (0%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Moderately differentiated adenocarcinoma 0 (0%) 1 (0,6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Papillary Adenocarcinoma 0 (0%) 0 (0%) 0 (0%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Endometrial Stromal Sarcoma DD Malignant Mixed 
Müllerian Tumor 
0 (0%) 0 (0%) 0 (0%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Endometrial Stromal Tumor 0 (0%) 1 (0,6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Endometrioid Adenocarcinoma  with squamous 
metaplasia 
0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (5%) 0 (0%) 0 (0%) 1 (0,2%) 
Endometrioid Adenocarcinoma, Well differentiated 0 (0%) 0 (0%) 0 (0%) 1 (1,1%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Nonkeratinizing Squamous Cell Carcinoma, intermediate 
cell type 
0 (0%) 1 (0,6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Polypoid Adenocarcinoma, well differentiated 0 (0%) 0 (0%) 1 (0,4%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0,2%) 
Total 26 (100%) 168 (100%) 248 (100%) 90 (100%) 
20 
(100%) 
6 (100%) 3 (100%) 560 (100%) 




The prevalence of endometrial 
lesions is listed in Table 1. Based on this 
table, the endometrial secretion phase was 
the most common finding in the 20-29 year 
age group (26.9%). Proliferation phase 
endometrium was the most common 
finding found in the age group 30-39 years 
(26.8%), 50-59 years (41.1%), 60-69 years 
(45%). and aged 80-89 years (66.7%). In 
the 40-49 years and 70-79 years age group, 
the most common finding is non-atypical 
endometrial hyperplasia (27,3% and 50% 
respectively). 
The result of endometrial irregular 
shredding was most commonly found in the 
40-49 age group (n=16/31;51.6%). 
Endometrial polyps were found mostly in 
the 30-39 age group (n=34/78;43.6%). 
Chronic endometritis was also found 
mostly in the 40-49 age group 
(11/23;47.8%), and endometrial lesions 
caused by prolonged progesterone exposure 
were commonly found in the 30-39 age 
group (n=7/13;53.8%). In the 50-59 age 
group, most findings were endometrial 
atrophy (n=2/3;66.7%) while in the 60-69 
age group, most of the findings were 
endometrial atrophy cystic changes 
(n=1/1;100%). 
Table 2. Age group domination for endometrial lesion 
Endometrial lesion Age group 
Percentage of most common 
age group in a finding * 
Long-standing progesterone effect 30-39 y.o 53.8%  (7/13) 
Endometrial polyp 30-39 y.o 43.6% (34/78) 
Irregular shedding 40-49 y.o 51.6% (16/31) 
Chronic Endometritis 40-49 y.o 47.8%  (11/23) 
Non-atypical and typical endometrial hyperplasia 40-49 y.o 
83.3% (10/12) – Atypical** 
55.3% (68/123) – Typical*** 
Endometrial atrophy 50-59 y.o 66.7%  (2/3) 
Endometrial malignancy 50-59 y.o 37.0% (10/27) 
 For example:7 out of 13 cases of long-standing progesterone effects were found in 30-39 y.o  
** 10 out of 12 cases of atypical hyperplasia found in 40-49 y.o 
*** 68 out of 123 cases of typical hyperplasia found in 40-49 y.o 
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Figure 4. Prevalence of Benign and Malignant Lesions across Age Group 
 
Figure 5. Endometrial Malignancy Distribution 
Endometrial malignancy were commonly 
found in 50-59 y.o (n=10/27;37.03%). 
Malignancies found in this research 
dominated by endometrioid 
adenocarcinoma (n = 23/27; 85.1%) 
followed by undifferentiated carcinoma 
(n=2/27;7.4%), non-keratinizing squamous 
cell carcinoma (n=1/27;3.7%), and 
endometrial stromal sarcoma tumor with 
Mixed Mullerian Tumor as its differential 
diagnosis (n=1/27;3.7%). Endometrioid 
carcinoma was mostly found in grade II 
(n=10/16;62.5%). 









< 50 years old 
Count 13 428 441 
4.39 0.000* % within Risiko 2.9% 97.1% 100.0% 
≥ 50 years old 
Count 14 105 119 
% within Risiko 11.8% 88.2% 100.0%   
Total 
Count 27 533 560   
% within Risiko 4.8% 95.2% 100.0%   
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Women at 50 years old and above have a 
4.39 times higher risk of malignancy than 
their peers.  This finding was statistically 
significant p = 0.000.
 
Figure 6. The trend of cases found from  2015-2017 
Prevalence of malignancy was 
unchanged in 3 years, while the benign 
lesion increased rate by 20% annually from 
145 cases in 2015, 176 cases in 2016, and 
212 cases in 2017. 
DISCUSSION 
 Irregular shedding of endometrium 
occurs due to regression failure of the 
corpus luteum lead to prolonging 
progesterone exposure. Irregular 
endometrial shedding was found across 
ages,  mostly in the 40-49 year age group (n 
= 16/31; 51.6%). The results are similar to 
research conducted at the Kandou Manado 
General Hospital which stated that most 
irregular shedding cases were at 41-50 
years old (33.87%) [4]. Also, research in 
Nigeria states that irregular shedding was 
found most frequently in the fourth decade 
as 43.3% [3]. However, another study states 
that the age of irregular shedding occurs in 
the fifth decade as much as 35.9% [5]. This 
difference might happen due to 
multifactorial influences such as genetics, 
ethnics or environmental such as diet, 
nutrition, and activities.[6]. 
 This study reported proliferation 
phase of the endometrium was 29.5%and 
secretory 14.7% with the age range of the 
endometrium in the proliferation phase 
varying at the age of 20-89, while the 
endometrium in the secretion phase was 
mostly found in the 20-29 year age group. 
Proliferative endometrium can be caused 
by contraceptive use and medications for 
abnormal uterine bleeding before curettage. 
Another study in Nigeria also found that the 
proliferation phase endometrium also 
dominates (21.7%) and secretion phase 
endometrium (12.4%) [3]. Research in Italy 
on women aged 30-40 years stated that the 
endometrium does not age, but only 
Epidemiologic Study Of......  Dewi S, Theodora I, Novita BD, Widyasari Y, Gunadi R, 




changes when there is hormonal 
administration or the menstrual cycle [7]. 
 The most commonly used low-dose 
oral contraceptive is progesterone, which 
inhibits proliferative changes in the 
endometrium's normal cycle [8]. In this 
study, it was found that endometrial lesions 
due to the effects of prolonged progesterone 
were mostly found in the 30-39 year age 
group (n = 7/13; 53.8%). This might be 
related to the age of women who use 
contraception, especially hormonal 
contraceptives that contain progesterone 
such as birth control pills, injection 
contraceptives, or IUD with progesterone. 
Prolonged progesterone exposure can also 
be caused by abnormal uterine bleeding 
treatment. 
 In this study, it was found that the 
prevalence of endometrial polyps was 
13.9%. The results of this study were higher 
than other studies in Nigeria, which only 
included 3.1% [3]. This difference could be 
due to differences in racial and ethnic 
characteristics in each population. In 
previous studies, it was found that 
menopause, the elderly (> 60 years), 
obesity, and diabetes mellitus are clinical 
parameters that can increase the risk of 
developing benign and malignant 
endometrial polyps. The highest number of 
cases of endometrial polyps in this study 
was found in the 30-39 year age group. This 
result is inconsistent with previous studies 
in which endometrial polyps were found to 
be the largest in the perimenopausal age 
group. The low number of cases in the 
younger age group may be due to the 
spontaneous regression mechanism of 
polyps, which are characteristic of changes 
in the endometrial cycle in women of 
reproductive age. 
 The number of endometrial polyps 
cases continued to decline, starting in the 
perimenopausal age group. Other studies 
have listed an increase in the prevalence of 
endometrial polyps with age due to 
prolonged exposure to estrogen and 
progesterone, which affects the 
proliferation and differentiation of the 
endometrium [9]. The results of another 
study in Denmark also stated that the 
prevalence of endometrial polyps would 
continue to increase with age [10]. 
 The prevalence of endometrial 
atrophy was found to be 0.5% and was 
found mostly in the 50-59 years age group. 
The prevalence of endometrial atrophy 
accompanied by cystic changes is only 
found in the 60-69 years age group. Our 
study was consistent with previous studies 
stating that atrophy in the endometrium was 
found mostly in post-menopausal women. 
This is due to the loss of endometrial 
stimulation by estrogen either externally or 
internally after menopause, which causes 
the endometrial walls to become thin and 
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eventually atrophy [11]. Endometrial walls 
that experience atrophy will cause minor 
injury to occur and are the most common 
cause of postmenopausal bleeding [12]. 
 The prevalence of chronic 
endometritis in this study was found to be 
4.1% and was mostly found in the 40-49 
year age group. Our study was consistent 
with a previous study in India, which stated 
that chronic endometritis was found mostly 
in perimenopausal age [13]. Transvaginal 
infection, intrauterine devices (IUD), 
submucosal leiomyoma, and endometrial 
polyps are the most common causes of 
chronic irritation of the endometrium, 
leading to chronic inflammatory reactions 
in the endometrium [11]. Chronic 
endometritis is mostly found in women of 
perimenopausal age, probably due to 
menstrual cycle irregularities during 
perimenopause. The endometrial 
proliferation phase has been associated 
with the incidence of plasma cell 
endometritis. The longer the duration of the 
proliferation phase during perimenopause 
increases the risk of developing 
endometritis [14]. 
The incidence of endometrial 
hyperplasia prevalence was highest in the 
40-49 years age group, those with and 
without atypia. This result was following 
the theory that endometrial hyperplasia 
occurs mostly in the perimenopausal age 
due to intermittent anovulation. With 
intermittent anovulation, there will be an 
absence of progesterone to counteract 
estrogen effects so that glandular 
proliferation continues [15]. However, the 
age at which endometrial hyperplasia 
occurs in Indonesia are younger if 
compared to the 2009 prevalence study in 
the United States with 63,688 samples who 
found that non-atypical endometrial 
hyperplasia was most prevalent at the age 
of 50-54, and atypic endometrial 
hyperplasia occurred mostly at the age of 
60-64 [16]. Apart from the risk factors for 
endometrial hyperplasia, the younger 
occurrence of endometrial hyperplasia in 
this study might be explained because of 
sample size at the age of 40-49 is three 
times larger at the age of 50-59. 
Most endometrial malignancies 
occurred at the age of 50-59, with the 
number of cases as much as 4.7% of all 
samples in this study. Previous studies on 
the prevalence of gynecological cancer in 
Indonesia in 2009 showed that the 
prevalence of endometrial cancer was 
mostly at the age of 45-54 years [17].  
Another prevalence study of endometrial 
cancer at Dokter Sutomo Hospital with a 
sample of 95 people showed that 
endometrial cancer occurred mostly in the 
age of 51-60 years [18]. The population of 
patients with endometrial cancer in 
Indonesia is younger than patients in the 
United States. The number of endometrial 
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cancer prevalence in the United States is 
highest in the 55-64 years age group 
(median 63 years) [19]. There are several 
probable reasons to explain this 
phenomenon. The first possibility is that the 
sample size in our study and the past 
prevalence study in Indonesia was still 
smaller than the sample size in the United 
States study. The second possibility is the 
existence of special risk factors that are 
owned by the population in Indonesia. The 
most common type of malignancy in the 
endometrium is endometrioid carcinoma. 
In theory, endometrioid carcinoma 
accounted for 83% of cases of endometrial 
malignancies [20]. However, our study 
found that endometrioid carcinoma only 
made 37.03% of all malignancies were 
present in this study. This may be due to the 
small sample of endometrial malignancy. 
The risk factors for endometrial 
hyperplasia and endometrial cancer are 
chronic estrogen exposure and a relative 
progesterone deficiency. This can occur 
due to increasing age, genetics, early 
menarche, late menopause, obesity, 
diabetes mellitus, PCOS, estrogen-
producing tumors, and 
immunosuppression. [21], [22]. Several 
genetic mutations cause endometrial 
malignancies, including PTEN Tumor 
Suppressor Gene, PIK3CA, KRAS, 
ARID1A, and TP53 [23]. The prevalence of 
this gene mutation is unknown in 
Indonesia.  
LIMITATION 
 There were some limitations in this 
study. The insufficient sample size of 
women aged 60 years and over may affect 
the prevalence rate of endometrial disease, 
particularly endometrial cancer. However, 
the sample size in this study was relatively 
superior compared to other studies in 
Surabaya. It is hoped that, with this large 
sample, the numbers obtained can be more 
representative of the actual situation.  
For further research, studies with 
larger sample sizes, more even age 
distribution, and detail clinical and 
epidemiological profiles are needed. 
Research is also necessary to investigate 
the prevalence of gene mutations or other 
factors which cause the younger occurrence 
of endometrial hyperplasia and cancer in 
Indonesia. 
CONCLUSION 
There were differences in the 
etiology of endometrial lesions based on 
age groups. At a younger age, causes of 
endometrial lesions include inflammatory 
lesions, hormonal influences, polyps, and 
hyperplasia. The risk of endometrial 
malignancy increased 4.39 times at the age 
above 50 years significantly (p = 0.00). The 
type of malignancy in the endometrium was 
dominated by endometrioid 
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adenocarcinoma The trend in the 
prevalence of malignancy did not increase 
in 3 years (2015 - 2017) while cases of 
benign lesions increased by 20% per year. 
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